Nervonix, a medical R&D company headquartered in Bozeman, MT, is cultivating technology that generates noninvasive 2D images of peripheral nerves. The images might ultimately be used to identify the location of nerves, providing the basis for pain
Nervonix, a medical R&D company headquartered in Bozeman, MT, is cultivating technology that generates noninvasive 2D images of peripheral nerves. The images might ultimately be used to identify the location of nerves, providing the basis for pain diagnosis and management by anesthesiologists, surgeons, and other clinicians, according to the company. A portable device is being designed to deliver real-time, high-resolution nerve images from a patient's bedside or the operating table. Nervonix is collaborating with Battelle Memorial Institute to develop the technology into a viable product, which could be commercially available as early as mid-2004, according to Nervonix. The company is now looking for commercial partners, OEMs, and distributors to assist in its development and marketing efforts.
European Society of Breast Imaging Issues Updated Breast Cancer Screening Recommendations
April 24th 2024One of the recommendations from the European Society of Breast Imaging (EUSOBI) is annual breast MRI exams starting at 25 years of age for women deemed to be at high risk for breast cancer.
Study Reveals Benefits of Photon-Counting CT for Assessing Acute Pulmonary Embolism
April 23rd 2024In comparison to energy-integrating detector CT for the workup of suspected acute pulmonary embolism, the use of photon-counting detector CT reduced radiation dosing by 48 percent, according to newly published research.